Multiple studies have shown that lysophospholipid (LPL), one of the phospholipid metabolites, is associated with fatty liver, steatohepatitis, diabetes, obesity, and even cancer (Grzelczyk and Gendaszewska-Darmach 2013). Here, LPL is linked to obesity disorder.